Circulating Biomarkers in Neuroendocrine tumours of the Enteropancreatic tract: Application to Diagnosis, Monitoring Disease, and as Prognostic indicators
Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumours (GEP-NETS): Results from the National Cancer Registry of Spain (RGETNE)